As of early 2026, Philips has not announced a global settlement in MDL 3014. Philips has reserved approximately $1.1 billion for litigation — but market analysts and plaintiff attorneys estimate total exposure at $4 to $6 billion if bellwether trials go unfavorably. The most analogous MDL precedent is the 3M Combat Arms Earplug litigation, which resolved for approximately $6 billion after adverse bellwether results.

Factors that increase your settlement value include: advanced cancer stage, longer duration of recalled device use, ozone cleaner use (higher exposure), younger age at diagnosis, stronger causation documentation, wrongful death, and claims in states that allow punitive damages. Factors that may reduce value include: minimal device use, absence of a cancer diagnosis, prior history of the same cancer type from other causes, and weak medical documentation.